ClearPoint Neuro, Inc. Quarterly report pursuant to sections 13 or 15(d)

Quarterly report pursuant to sections 13 or 15(d)

Note 3 - Inventory

Note 3 - Inventory

3 Months Ended

Mar. 31, 2013

3. Inventory

Inventory consists of the following as of:

	March 31, 2013		December 31, 2012
Work in process	$	543,945	$	494,290
Software license inventory		379,500		344,500
Finished goods		138,195		60,912
Inventory included in current assets		1,061,640		899,702
Software license inventory		1,067,500		1,137,500
	$	2,129,140	$	2,037,202

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References + Details